TCI Wealth Advisors’s Galectin Therapeutics GALT Stock Holding History

TCI Wealth Advisors’s Portfolio GALT Stock Details GALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-300	Closed	-$1K	–	2364
2021 Q3	$1K	Hold	300	–	–	﹤0.01%	2262
2021 Q2	$1K	Hold	300	–	–	﹤0.01%	2210
2021 Q1	$1K	Hold	300	–	–	﹤0.01%	2064
2020 Q4	$1K	Hold	300	–	–	﹤0.01%	1378
2020 Q3	$1K	Hold	300	–	–	﹤0.01%	1322
2020 Q2	$1K	Hold	300	–	–	﹤0.01%	1253
2020 Q1	$1K	Hold	300	–	–	﹤0.01%	1240
2019 Q4	$1K	Hold	300	–	–	﹤0.01%	1339
2019 Q3	$1K	Hold	300	–	–	﹤0.01%	1285
2019 Q2	$1K	Hold	300	–	–	﹤0.01%	1198
2019 Q1	$2K	Hold	300	–	–	﹤0.01%	1025
2018 Q4	$1K	Hold	300	–	–	﹤0.01%	1207
2018 Q3	$2K	Hold	300	–	–	﹤0.01%	1034
2018 Q2	$2K	Hold	300	–	–	﹤0.01%	1080
2018 Q1	$1K	Hold	300	–	–	﹤0.01%	1138
2017 Q4	$1K	Hold	300	–	–	﹤0.01%	1187
2017 Q3	$1K	Hold	300	–	–	﹤0.01%	1110
2017 Q2	$1K	Hold	300	–	–	﹤0.01%	1130
2017 Q1	$1K	Hold	300	–	–	﹤0.01%	1088
2016 Q4	$0	Hold	300	–	–	﹤0.01%	1393
2016 Q3	$0	Hold	300	–	–	﹤0.01%	1373
2016 Q2	$0	Hold	300	–	–	﹤0.01%	1324
2016 Q1	$0	Hold	300	–	–	﹤0.01%	1350
2015 Q4	$0	Hold	300	–	–	﹤0.01%	1043
2015 Q3	$1K	Hold	300	–	–	﹤0.01%	882
2015 Q2	$1K	Hold	300	–	–	﹤0.01%	880
2015 Q1	$1K	Hold	300	–	–	﹤0.01%	801
2014 Q4	$1K	Hold	300	–	–	﹤0.01%	800
2014 Q3	$2K	Hold	300	–	–	﹤0.01%	730
2014 Q2	$4K	Hold	300	–	–	﹤0.01%	637
2014 Q1	$5K	Buy	+300	New	+$4.27K	﹤0.01%	548

Other funds holding GALT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GWM

Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCI Wealth Advisors's GALT Position: Q4 2021 in Review

TCI Wealth Advisors sold out of Galectin Therapeutics (GALT) in Q4 2021, closing a stake of 300 shares — an estimated $1K sold.

TCI Wealth Advisors first reported a position in GALT in Q1 2014 and held it in 31 quarters. The position peaked at $5K in Q1 2014. 55 funds tracked by Wall St. Rank hold GALT as of Q4 2021.

TCI Wealth Advisors reported no remaining Galectin Therapeutics position as of Q4 2021 after selling out during the quarter.
TCI Wealth Advisors sold 300 Galectin Therapeutics shares in Q4 2021, an estimated $1K.
TCI Wealth Advisors first reported a position in Galectin Therapeutics in Q1 2014 and held it in 31 quarters.
TCI Wealth Advisors's Galectin Therapeutics position peaked at $5K in Q1 2014.
55 funds tracked by Wall St. Rank held Galectin Therapeutics as of Q4 2021.

Based on TCI Wealth Advisors's 13F filing for Q4 2021, filed 24 Jan 2022.